JPWO2019213558A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2019213558A5 JPWO2019213558A5 JP2020561786A JP2020561786A JPWO2019213558A5 JP WO2019213558 A5 JPWO2019213558 A5 JP WO2019213558A5 JP 2020561786 A JP2020561786 A JP 2020561786A JP 2020561786 A JP2020561786 A JP 2020561786A JP WO2019213558 A5 JPWO2019213558 A5 JP WO2019213558A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- renal
- therapeutic pharmaceutical
- composition according
- receptor agonist
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862666675P | 2018-05-03 | 2018-05-03 | |
| US62/666,675 | 2018-05-03 | ||
| IN201841019588 | 2018-05-25 | ||
| IN201841019588 | 2018-05-25 | ||
| PCT/US2019/030652 WO2019213558A1 (en) | 2018-05-03 | 2019-05-03 | Alterations in endothelin receptors following hemorrhage and resuscitation by centhaquin |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021523125A JP2021523125A (ja) | 2021-09-02 |
| JPWO2019213558A5 true JPWO2019213558A5 (https=) | 2022-05-13 |
| JP2021523125A5 JP2021523125A5 (https=) | 2022-05-13 |
| JP7458032B2 JP7458032B2 (ja) | 2024-03-29 |
Family
ID=68386694
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020561786A Active JP7458032B2 (ja) | 2018-05-03 | 2019-05-03 | 出血およびセンタキンによる蘇生後のエンドセリン受容体の変化 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20210169978A1 (https=) |
| EP (2) | EP3813942B1 (https=) |
| JP (1) | JP7458032B2 (https=) |
| CN (1) | CN112469474A (https=) |
| AU (1) | AU2019262612B2 (https=) |
| BR (1) | BR112020022395A2 (https=) |
| ES (1) | ES2978951T3 (https=) |
| PL (1) | PL3813942T3 (https=) |
| WO (1) | WO2019213558A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2010241564B2 (en) | 2009-04-30 | 2014-07-31 | Midwestern University | Novel therapeutic treatments using centhaquin |
| JP2024517334A (ja) * | 2021-05-11 | 2024-04-19 | ファーマズ，インコーポレイテッド | コロナウイルス疾患（ｃｏｖｉｄ－１９）における急性呼吸窮迫症候群（ａｒｄｓ）の治療のための医薬組成物及び方法 |
| US20240207356A1 (en) * | 2022-12-26 | 2024-06-27 | Pharmazz, Inc. | Composition and method for wound healing and repair of damaged nerves |
| US20240382461A1 (en) * | 2023-05-15 | 2024-11-21 | Pharmazz, Inc. | Pharmaceutical composition and method for prevention and treatment of hearing loss |
| IN202411028038A (https=) * | 2024-04-04 | 2025-05-23 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0597891A (ja) * | 1991-04-24 | 1993-04-20 | Banyu Pharmaceut Co Ltd | 血管弛緩ペプチド類 |
| CA2578709C (en) * | 2004-06-17 | 2010-06-15 | Virun, Inc. | Compositions comprising a mucoadhesive protein and an active principle for mucosal delivery of said agents |
| JP2009506119A (ja) * | 2005-08-31 | 2009-02-12 | ユニバーシティ オブ テネシー リサーチ ファウンデーション | 選択的アンドロゲン受容体モジュレーターを用いる腎疾患、熱傷、創傷および脊髄損傷の処置 |
| US9829494B2 (en) | 2005-12-01 | 2017-11-28 | Adrenomed Ag | Methods of treatment using ADM antibodies |
| US20080242687A1 (en) * | 2007-04-02 | 2008-10-02 | Auspex Pharmaceuticals, Inc. | Substituted pyrimidines |
| AU2008237062A1 (en) | 2007-04-10 | 2008-10-16 | Auspex Pharmaceuticals, Inc. | Substituted deuterium enriched thiophenes for the treatment of hypertension |
| EP2545920A1 (en) | 2007-08-22 | 2013-01-16 | Abbott GmbH & Co. KG | Therapy for complications of diabetes |
| AU2010241564B2 (en) * | 2009-04-30 | 2014-07-31 | Midwestern University | Novel therapeutic treatments using centhaquin |
| US20130296331A1 (en) | 2010-11-26 | 2013-11-07 | Technion Research And Development Foundation Ltd. | Compositions and methods for ameliorating renal dysfunction induced by renal hypoperfusion or acute kidney injury |
| BR112015004643A2 (pt) | 2012-08-31 | 2017-07-04 | Univ Midwestern | métodos e composições para ressucitação hipotensiva |
| AU2014287427B2 (en) | 2013-07-08 | 2019-11-21 | Midwestern University | Compositions and methods for treating neuropsychiatric disorders using an endothelin-B receptor agonist |
-
2019
- 2019-05-03 PL PL19796519.7T patent/PL3813942T3/pl unknown
- 2019-05-03 AU AU2019262612A patent/AU2019262612B2/en active Active
- 2019-05-03 EP EP19796519.7A patent/EP3813942B1/en active Active
- 2019-05-03 ES ES19796519T patent/ES2978951T3/es active Active
- 2019-05-03 WO PCT/US2019/030652 patent/WO2019213558A1/en not_active Ceased
- 2019-05-03 JP JP2020561786A patent/JP7458032B2/ja active Active
- 2019-05-03 BR BR112020022395-6A patent/BR112020022395A2/pt not_active Application Discontinuation
- 2019-05-03 US US17/052,473 patent/US20210169978A1/en active Pending
- 2019-05-03 CN CN201980038669.0A patent/CN112469474A/zh active Pending
- 2019-05-03 EP EP24163271.0A patent/EP4364811A3/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021523125A5 (https=) | ||
| Skoutakis et al. | Review of diclofenac and evaluation of its place in therapy as a nonsteroidal antiinflammatory agent | |
| Carling et al. | Nephrotoxicity associated with cephalothin administration | |
| JP2013532635A (ja) | トロンボキサン−ａ２受容体アンタゴニストでの肝腎症候群および肝性脳症の治療方法 | |
| JP2023115271A5 (https=) | ||
| CN112469474A (zh) | 出血和centhaquin引起的复苏后内皮素受体的变化 | |
| McCormick et al. | Management of hepatorenal syndrome | |
| JPWO2019213558A5 (https=) | ||
| CN115006384A (zh) | 铁死亡抑制剂在制备抑制索拉非尼所致心脏毒性药物中的应用 | |
| EP0059148A1 (fr) | Le chlorure de gallium, nouveau médicament anti-cancéreux | |
| PERRIER et al. | Malignant pheochromocytoma masquerading as acute pancreatitis—a rare but potentially lethal occurrence | |
| Gelman et al. | Acute renal failure after total hip replacement. | |
| US6620834B1 (en) | Medicinal compositions for treating colorectal cancer | |
| JPS6045518A (ja) | 抗シヨツク剤 | |
| Kim et al. | Skin necrosis after a low-dose vasopressin infusion through a central venous catheter for treating septic shock | |
| JP5018478B2 (ja) | 尿毒症改善のための治療剤および処置方法 | |
| EP1203585B1 (en) | Anti-ischemic agent | |
| JP2019038858A (ja) | ペマフィブラートを含有する医薬 | |
| US4798811A (en) | Combination preparation | |
| KR20010092751A (ko) | 다발성 골수종의 골 병변 치료용 의약 조성물 | |
| CN107308121A (zh) | 肝脏再生的治疗剂 | |
| CN113440614A (zh) | 一种用于治疗类风湿性关节炎的组合物及其应用 | |
| Allegretti et al. | A Phase 2 study of OCE-205, a novel, selective vasopressin receptor mixed agonist-antagonist: Positive proof-of-concept established in subjects with cirrhosis and hepatorenal syndrome–acute kidney injury (HRS-AKI) | |
| CN120459089B (zh) | 替莫唑胺和二甲双胍联用在治疗肝癌中的应用 | |
| WO1998020888A1 (en) | Aids remedy |